Autologous Infusion of Expanded Mobilized Adult Bone Marrow-Derived CD34+ Cells Into Patients With Alcoholic Liver Cirrhosis
Authors:
- 1 August 2008
- journal article
- clinical trial
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 103 (8) , 1952-1958
Abstract
Recent advances in regenerative medicine, including hematopoietic stem cell (HSC) transplantation, have brought hope for patients with severe alcoholic liver cirrhosis (ALC). The aim of this study was to assess the safety and efficacy of administering autologous expanded mobilized adult progenitor CD34+ cells into the hepatic artery of ALC patients and the potential improvement in the liver function. Nine patients with biopsy-proven ALC, who had abstained from alcohol for at least 6 months, were recruited into the study. Following granulocyte colony-stimulating factor (G-CSF) mobilization and leukapheresis, the autologous CD34+ cells were expanded in vitro and injected into the hepatic artery. All patients were monitored for side effects, toxicities, and changes in the clinical, hematological, and biochemical parameters. On average, a five-fold expansion in cell number was achieved in vitro, with a mean total nucleated cell count (TNCC) of 2.3 × 108 pre infusion. All patients tolerated the procedure well, and there were no treatment-related side effects or toxicities observed. There were significant decreases in serum bilirubin (P < 0.05) 4, 8, and 12 wk post infusion. The levels of alanine transaminase (ALT) and aspartate transaminase (AST) showed improvement through the study period and were significant (P < 0.05) 1 wk post infusion. The Child-Pugh score improved in 7 out of 9 patients, while 5 patients had improvement in ascites on imaging. It is safe to mobilize, expand, and reinfuse autologous CD34+ cells in patients with ALC. The clinical and biochemical improvement in the study group is encouraging and warrants further clinical trials.Keywords
This publication has 29 references indexed in Scilit:
- Improved Liver Function in Patients with Liver Cirrhosis After Autologous Bone Marrow Cell Infusion TherapyStem Cells, 2006
- Characterization and Clinical Application of Human CD34 + Stem/Progenitor Cell Populations Mobilized into the Blood by Granulocyte Colony‐Stimulating FactorStem Cells, 2006
- Portal Application of Autologous CD133 + Bone Marrow Cells to the Liver: A Novel Concept to Support Hepatic RegenerationStem Cells, 2005
- Long‐term prognosis of patients with alcoholic liver cirrhosis: a 15‐year follow‐up study of 100 Norwegian patients admitted to one unitScandinavian Journal of Gastroenterology, 2004
- The new stem cell biology: something for everyoneMolecular Pathology, 2003
- Liver transplantation for chronic liver disease: advances and controversies in an era of organ shortages2002
- Hepatocytes from non-hepatic adult stem cellsNature, 2000
- Liver from bone marrow in humansHepatology, 2000
- Alcoholic liver diseasePostgraduate Medical Journal, 2000
- A prospective study of alcoholic liver disease and mortalityJournal of Hepatology, 1992